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Obesity is a metabolic disease that is assuming epidemic proportions. Obesity is 
caused by an imbalance between energy intake and energy expenditure, resulting in 
an excess of body fat. Obesity-associated diseases include diabetes, insulin 
resistance, dyslipidemia, liver steatosis, hypertension, heart diseases, and increased 
incidence of certain cancers. Few pharmacological approaches are available for the 
treatment of obesity, apart from dieting and changes in lifestyle, and new drugs and 
strategies are required. Two types of adipose tissue are present in mammals, white 
and brown (WAT and BAT, respectively), which have distinct phenotypes and 
functions. White adipocytes are unilocular, with a large lipid droplet, whereas brown 
adipocytes are multilocular and have many lipid droplets. The function of WAT is to 
store energy. In contrast, BAT dissipates energy, producing heat at the expenses of 
lipid combustion, a process that is accomplished by uncoupling protein 1 (UCP1), 
which is a BAT-specific mitochondrial protein that by uncoupling oxidative 
phosphorylation produces heat instead of ATP. The main activators of UCP1 are cold 
exposure and adrenergic stimulation, but many other hormones, including thyroid 
hormones, increase UCP1 activity. Analysis of the lineage of brown and white 
adipocytes has revealed that each has a different embryonic origin. Surprisingly, brown 
adipocytes have a myogenic origin and express Myf5, which is also found in myoblasts 
. The differentiation of brown and white adipocytes can be characterized using a panel 
of markers. In WAT, it is possible to find clusters of adipocytes that have been called 
brite (brown-white) or beige adipocytes. They are multilocular and express UCP1, as 
well as Cidea and other markers of brown adipocytes. They are present in discrete 
amounts and are more frequent in certain anatomical locations, such as the inguinal fat 
in rodents. Brite adipocytes are distinct from brown adipocytes with regard to their 
embryonic origin and gene expression signature. The presence, abundance, and 
activity of brite adipocytes are regulated in a different way than brown adipocytes. 
Many experimental models, especially mouse models with deletion of a single gene, 
have shown that mice were leaner when BAT was more active or when brite 
adipocytes were induced, whereas a loss of function of BAT led to increases in the 
percentage of body fat or to insulin resistance. Mice are resistant to weight gain when 
brown fat activity is increased. This means that by increasing the activity of BAT a 
reduction in metabolic disease can be achieved. Many groups have attempted to 
identify the processes that induce WAT to brite adipocyte transition, to determine if 
BAT and brite adipocytes are the same or different cells, and to establish the 
mechanisms of reactivation or induction of BAT activity. In this issue of the American 
Journal of Physiology-Cell Physiology, Elsen et al. characterize the induction of UCP1 
in response to BMP7 and BMP4 in human white adipocytes. They also show that 
BMP4, described to be involved in white adipocyte commitment, induces UCP1 in 
human white adipocytes as well as other markers of browning [peroxisome proliferator-
activated receptor- (PPAR) and PPAR coactivator 1 (PGC1)], and decreases markers 
of white adipocytes (TCF21). The transition to brite adipocytes can be followed using 
CD137 as a marker of browning of human adipocytes. In 2009, three different groups 
reported the presence of BAT in adult humans and its modulation by high body mass 
index, sex, and age. Previously, several groups reported the presence of BAT in 
humans, but from 2009 onwards it became clear that BAT could be a strategy to fight 
against obesity. Both BAT and brite adipocytes have been found in humans. However, 
it still remains to be proven that active BAT in humans is able to fight obesity.  
Many questions remain to be answered: Which are the regulators of the transition of 
white into brown or beige adipocytes? Which are the best anatomical locations to 
undergo such transformation? Are the mechanisms and processes similar in mice and 
humans? Are brite/beige adipocytes a cellular entity that is distinctly different from 
brown and white adipocytes, as indicated by some reports? In addition, moreover, how 
much might the activation of BAT and increased production of brite adipocytes 
contribute to increased energy expenditure? The work of Elsen et al. advances our 
understanding of adipose cell physiology, which may hold the key to effective obesity 
prevention and treatment.  
 
